GFS Advisors »

Crispr Therapeutics shares owned by GFS Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by GFS Advisors from 13F filings

Historical chart of GFS Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by GFS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by GFS Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $427k 13k 34.18

More positions owned by GFS Advisors

Alphabet Cap Stk Cl A (GOOGL)
Crowdstrike Hldgs Cl A (CRWD)
FedEx Corporation (FDX)
Core & Main Cl A (CNM)
Tesla Motors (TSLA)
Nasdaq Omx (NDAQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Rus 1000 Val Etf (IWD)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Walt Disney Company (DIS)
Cardinal Health (CAH)
Ishares Tr Msci Acwi Etf (ACWI)
Willis Towers Watson SHS (WTW)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for GFS Advisors

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Susquehanna International
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Two Sigma Investments

View all funds holding Crispr Therapeutics